Newsletter | October 13, 2021

10.13.21 -- Tackling The Challenges Of Biologics Development And Manufacturing

 
3 Key Considerations When Choosing A Partner For Your Tech Transfer
 

One way to streamline tech transfer is to partner with a CMO demonstrating a proven track record across the entire drug development and manufacturing continuum.

Driving Continuous Improvement With A Fully Integrated Quality System
 

A well-designed quality system has a global scope, incorporating guidelines from all relevant markets and assuring data quality and integrity through adherence to quality standards, policies, and procedures.

Create Amorphous Solid Dispersions Using Hot Melt Extrusion
 

ASDs improve bioavailability to provide acceptable in vivo performance. However, ASD production requires an enabling technology. Spray drying and hot melt extrusion (HME) are among the most widely applied technologies.

Tackling The Challenges Of Biologics Development And Manufacturing
 

Biologics are a growing, promising solution to address unmet medical needs. It is critical to have the right manufacturing partner to minimize challenges as a therapy moves from discovery to commercialization.

The Value Of Expertise In The Aseptic Fill/Finish Of Biologics
 

Aseptic fill/finish manufacturing is especially critical for highly valuable biologics drug substances, since with vast amounts of time and resources invested upstream, any errors resulting in loss of product at such a late stage can be catastrophic.

Expedite Commercial Launch Readiness For ADC Manufacturing
 

An effective strategy will reduce the probability of late-stage process, analytical, or manufacturing site changes that could put chemistry, manufacturing, and controls (CMC) activities on the critical path.

Drug Development From The Patient’s Perspective
 

Positive outcomes are dependent on the patient’s experience with the therapies we create. How is patient-centricity influencing the therapy development process today, and how will the industry adapt for further patient-centric improvement?

Solutions